Research Article
Clinical Features of COVID-19 Patients with Diabetes and Secondary Hyperglycemia
Table 1
The basic informations of the patients with COVID-19 (
).
| | Characteristics | , (%) |
| | Age () | 47.00 (35.00-56.00) | | Gender | | | Male | 48 (60.00) | | Female | 32 (40.00) | | Severe cases (, %) | 55 (68.75) | | Mild cases (, %) | 25 (31.25) | | Symptoms | | | Fever (, %) | 68 (85.00) | | Fatigue (, %) | 30 (37.5) | | Cough (, %) | 45 (56.25) | | Chest tightness (, %) | 27 (33.75) | | Dyspnea (, %) | 8 (10.00) | | Diarrhea (, %) | 9 (11.39) | | Incubation (d) | 6.00 (4.00-9.00) | | Hs-CRP (μmol/L) | 14.00 (3.80-41.60) | | Leukocyte () | 5.34 (4.12-6.61) | | Platelet () | 163.00 (129.00-213.50) | | Lymphocyte percentage (%) | 21.10 (10.83-31.20) | | Neutrophils percentage (%) | 70.15 (59.05-80.05) | | Lymphocyte () | 1.06 (0.67-1.49) | | Neutrophil () | 3.57 (2.30-5.25) | | Calcitonin zymogen (ng/ml) | 0.14 (0.10-0.18) | | ESR (mm/h) | 45.00 (16.50-65.75) | | LDH (U/L) | 237.00 (182.50-302.00) | | Creatinine (μmol/L) | 69.00 (59.25-80.00) | | Urea nitrogen (mmol/L) | 4.06 (2.99-5.60) | | ALT (IU/L) | 24.00 (15.00-42.00) | | AST (IU/L) | 26.50 (21.00-36.75) | | ALP (IU/L) | 59.50 (46.00-71.00) | | γ-GGT (IU/L) | 29.50 (18.50-50.25) | | TB (μmol/L) | 14.50 (11.10-18.85) | | CD4/CD8 | 1.42 (1.19-1.91) | | CD4 (cell/μl) | 553.00 (383.50-869.75) | | CD8 (cell/μl) | 367.17 (266.54-617.98) | | CD3 (cell/μl) | 1086.50 (687.50-1625.25) | | IL-6 (pg/ml) | 6.13 (5.11-7.98) | | D-dimer (μg/ml) | 0.24 (0.14-0.45) | | CK (IU/L) | 86.70 (52.65-141.03) | | CK-MB (U/L) | 10.95 (8.68-15.10) | | hs-Tn (μg/L) | 0.09 (0.06-0.27) | | PT(s) | 14.45 (13.48-16.00) | | APTT(s) | 36.50 (33.48-41.10) |
|
|
Data are shown as medians and interquartile ranges. Hs-CRP: high-sensitive C-reactive protein; PCT: procalcitonin; ESR: erythrocyte sedimentation rate; LDH: lactate dehydrogenase; ALT: alanine aminotransferase; AST: aspartate aminotransferase; ALP: alkaline phosphatase; γ-GGT: gamma-glutamyltran; TB: total bilirubin; IL-6: interleukin-6; CK: creatine kinase; CK-MB: creatine kinase isoenzyme-MB; hs-TnI: highly sensitive troponin I; PT: prothrombin time; APTT: activated partial thromboplastin time.
|
